Scientists test 'Cancer-Fighting Virus' in patients with advanced tumors
NCT ID NCT04695327
Summary
This early-stage trial tested the safety of a new experimental treatment called TILT-123, a genetically modified virus designed to infect and kill cancer cells. The virus was injected directly into tumors in 32 patients with advanced solid cancers that had stopped responding to standard treatments. The main goal was to find a safe dose and understand the side effects of this new type of therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Docrates Cancer Center
Helsinki, Uusima, 00180, Finland
-
Helsinki University Hospital
Helsinki, Uusima, 00029, Finland
Conditions
Explore the condition pages connected to this study.